New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 31, 2014
05:45 EDTMYGN, AETAetna BRCA testing policy bulletin not a change, says William Blair
William Blair says shares of Myriad Genetics (MYGN) dropped 2% Friday after Aetna (AET) issued a clinical policy bulletin update for BRCA testing that changed the word "Myriad" to "Laboratory." The firm believes the bulletin does not represent a change to the status quo since a number of labs now offer BRCA testing. William Blair keeps an Outperform rating on Myriad.
News For MYGN;AET From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 23, 2015
15:46 EDTMYGNPiper Jaffray's medtech analysts hold an analyst/industry conference call
Subscribe for More Information
January 20, 2015
07:07 EDTMYGNMyriad RBM joins Institut Pasteur in TB collaboration
Myriad RBM, a wholly owned subsidiary of Myriad Genetics, announced that it will assist the Institut Pasteur in a public-private research collaboration to fight the global tuberculosis, or TB, epidemic. This research project is funded by the Bill & Melinda Gates Foundation through a grant to the Institut Pasteur. The proof-of-concept study will evaluate patients with latent and active TB infections who are affiliated with the South African Tuberculosis Vaccine Initiative clinical study sites. The goals of this study are to field-test Myriad RBM's TruCulture system as a point-of-care blood collection and immune response monitoring method and to stratify patients with active and latent tuberculosis.
January 18, 2015
17:40 EDTAETAetna customers can switch coverage after mistake, Bloomberg says
Aetna is being investigated by the U.S. for misleading elderly and disabled people about which pharmacies would fill prescriptions in Medicare drug plans the health insurer sold them, says Bloomberg. According to the Bloomberg report, customers will be able to quit their coverage and choose a new plan this year as a result. Raymond Thorn, a spokesman for the Centers for Medicare and Medicaid Services said Aetna may be fined or prohibited from enrolling new Medicare customers if the agency determines it intentionally misled Medicare patients, added Bloomberg. Reference Link
January 16, 2015
14:54 EDTAETGilead at high of day, up 3% after reaching hep C drug pact with Aetna
14:46 EDTAETAetna, Gilead confirm discount pricing for hepatitis C drugs Harvoni, Sovaldi
Subscribe for More Information
10:47 EDTAETBofA/Merrill healthcare facilities analyst analyst/industry conference call
Healthcare Facilities & Managed Care Analyst Bressler discusses the legislative and regulatory outlook for the industry for 2015 on an Analyst/Industry conference call to be held on January 23 at 2 pm.
January 15, 2015
07:59 EDTMYGNAmerican Society of Clinical Oncology to hold a symposium
Subscribe for More Information
January 13, 2015
07:58 EDTAETAetna sees 2014 total medical membership exceeding 23.4M member view
Aetna CEO Mark Bertolini will meet with investors and analysts before and after a presentation at the 2015 J.P. Morgan Healthcare Conference and report that the company projects that its year-end 2014 total medical membership will exceed its previously disclosed projection of approximately 23.4M members, Aetna disclosed. Bertolini will also report that, based on results of the Medicare Annual Election Period and the Individual Public Health Insurance Exchange open enrollment period to date, Aetna projects that its 1Q15 Medicare Advantage and Individual Public Exchange membership will exceed its previous projections.
07:55 EDTAETAetna backs FY15 operating EPS view of at least $6.90, consensus $7.15
Aetna backs FY15 operating revenue projection of at least $62B, consensus $62.55B.
07:54 EDTAETAetna reaffirms FY14 operating EPS at high-end of $6.60-$6.70, consensus $6.68
Subscribe for More Information
06:36 EDTAETAetna to increase wages for lowest-paid workers, WSJ reports
Subscribe for More Information
January 12, 2015
07:17 EDTMYGNJPMorgan to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use